On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.
Departed
Matt Korenberg
Independent Director and Chairman of Audit Committee
On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
On October 5, 2024, the board of directors (the “ Board ”) of C3.ai, Inc. (the “ Company ”) elected General John E. Hyten, Ret. to the Board, effective immediately.
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
Departed
Gerald Bruce
Director
Virpax Pharmaceuticals, Inc.
Effective
2024-10-05
Filed
October 9, 2024, 7:59 PM ET
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.
the Company also announced that, effective as of the Effective Date, B. Andrew Rose will retire as the Company’s President and CEO and as a member of the Board.
Appointed
William T. White
member of the board of directors
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2024-10-08
Filed
October 8, 2024, 7:59 PM ET
On October 8, 2024, our board of directors elected William T. White as a member of the board of directors, effective October 8, 2024.
Departed
Dr. Earl C. Currin, Jr.
member of the board of directors
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2024-10-08
Successor
William T. White
Filed
October 8, 2024, 7:59 PM ET
Mr. White was recommended to the nominating committee by Southside Electric Cooperative to replace Dr. Earl C. Currin, Jr.
the Company appointed Michael Stirzaker, former Chair of the Base Resources Board of Directors (the " Base Resources Board "), to the Board of Directors of Energy Fuels (the " Board ").
Departed
Dalton Wright
Member of the Board of Directors
Angel Studios, Inc.
Effective
2024-10-03
Filed
October 8, 2024, 7:59 PM ET
On October 3, 2024, Mr. Dalton Wright tendered his resignation as a member of the Board of Directors (the “Board”) of Angel Studios, Inc. (the “Company,” “we,” “us,” or “our”) effective as of October 3, 2024.
Departed
Terry Considine
director
Apartment Income REIT, L.P.
Effective
2024-10-02
Filed
October 8, 2024, 7:59 PM ET
On October 2, 2024 (the “Separation Date”), effective immediately, Terry Considine stepped down as Chief Executive Officer of Apartment Income REIT, L.P. (the “Partnership”) and as a director of the board
On October 2, 2024, Craig Ballaron, a member of the Board of Directors (the “Board ”) of Verrica Pharmaceuticals Inc. (the “ Company ”), notified the Company that he was resigning from the Board and all committees of the Board, effective immediately.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.
On October 7, 2024, the Board of Directors of Neonode Inc. (the “Company”) elected Peter Kruk to the Company’s board of directors (the “Board”) as a Class II director, effective October 7, 2024.
On October 2, 2024, Michael Fahy was appointed to the board of directors of TSS, Inc. (the “Company”) as a Class II director for a term expiring at the 2025 Annual Meeting of Stockholders and until his successor is duly elected and qualified.
On October 2, 2024, the board of directors (the “ Board ”) of Bunker Hill Mining Corp. (the “ Company ”) appointed Kelli Kast as a director of the Company effective immediately.
On October 7, 2024, Jeffrey T. Diehl, a member of the Board of Directors (the “Board”) of Paylocity Holding Corporation (the “Company”), notified the Board of his decision not to stand for reelection at the Company’s 2025 annual meeting of stockholders to be held on December 5, 2024.
On October 8, 2024, the Board of Directors (the “Board”) of LivaNova PLC (the “Company”) appointed Susan Podlogar to the Board and as a member of the Compensation and Human Capital Management Committee of the Board.
Sasa Vasiljevic has been appointed as an independent director
Appointed
Erik Harris
Director
Inozyme Pharma, Inc.
Effective
2024-10-03
Filed
October 7, 2024, 7:59 PM ET
appointed Erik Harris as a director of the Company, effective October 3, 2024.
Departed
Horst G. Zerbe
Director
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
Departed
Dwight Gorham
Director
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
Departed
Mark Nawacki
Director
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
Departed
Monika Trzcinska
Director
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
Departed
Bernd J. Melchers
Director
IntelGenx Technologies Corp.
Effective
2024-10-02
Filed
October 7, 2024, 7:59 PM ET
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
On October 2, 2024, Daniel Hagen informed the board of directors (the “Board”) of Kratos Defense & Security Solutions, Inc. (the “Company”) of his decision to resign from the Board and, in connection with his resignation from the Board, all related Board committees, effective immediately.
Appointed
David Voyticky
Director
VICTORY CLEAN ENERGY, INC.
Effective
2024-10-01
Filed
October 7, 2024, 7:59 PM ET
On October 1, 2024, the shareholders by majority consent elected David Voyticky to serve as a director of the Company, effective October 1, 2024.
On October 2, 2024, Josh Baumgarten informed the board of directors (the “Board”) of TPG Inc. (the “Company”) that he is resigning from his position as a director of the Company, effective as of October 7, 2024, and intends to transition from the Company as of year-end.
Michael Bruen notified the Company of his planned retirement from the Company, effective as of January 3, 2025, and his resignation as President of the Company and as a member of the Company’s board of directors (the “Board”), effective as of October 4, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.